新天地(301277.SZ)：富马酸亚铁获得化学原料药上市申请批准通知书
Henan Newland Pharmaceutical Henan Newland Pharmaceutical (SZ:301277) Ge Long Hui A P P·2025-12-09 08:17

Core Viewpoint - Xintiandi (301277.SZ) has received approval from the National Medical Products Administration for the raw material drug Ferrous Fumarate, which is used for the prevention and treatment of iron deficiency anemia [1] Group 1 - The approval includes the issuance of the "Chemical Raw Material Drug Marketing Application Approval Notice" for Ferrous Fumarate [1] - Ferrous Fumarate is an iron supplement that improves hemoglobin synthesis and alleviates symptoms related to anemia [1]